This site is intended for healthcare professionals
ACARE podcast hero
All Things Angioedema and Urticaria: Podcasts
Declaration of sponsorship GA²LEN UCARE/ACARE

Test tab 2

Declaration of sponsorship GA²LEN UCARE/ACARE
Last updated:8th Apr 2024
Published:28th Feb 2024

Join Dr Thomas Buttgereit, dermatologist and allergist at the Angioedema Center of Reference and Excellence (ACARE), Berlin, and other experts in this podcast series to hear the latest news and views in hereditary angioedema (HAE).

A new episode is published every 2 weeks as part of the ACARE LevelUp Educational Program.

Please provide feedback and offer your suggestions for future topics and expert selection here

Complete feedback form

Episode 14 – Collaboration in HAE

“There are a lot of doctors that should know about angioedema.” Ear, nose and throat specialist Dr Janina Hahn joins Dr Thomas Buttgereit to discuss the importance of implementing an interdisciplinary approach in HAE, including tips on overcoming challenges.

For more information about the GA2LEN ACARE network and its activities please visit https://acare-network.com/.

Episode 4 – Androgens in hereditary angioedema

Dr Thomas Buttgereit is joined by Dr Carolina Vera to discuss the use of attenuated androgens in the treatment of hereditary angioedema and their associated risks and side effects. Both exerts delve into the safety, ethical considerations and alternative treatment options to using androgens for the treatment of hereditary angioedema. Dr Vera concludes the discussion with an in-depth explanation of the SHAERPA project, focusing on the discontinuation of androgen use in individuals with angioedema, and the benefits this project can have in providing guidance on alternative medications.

For more information about the GA2LEN ACARE network and its activities please visit https://acare-network.com/. Additional resources relating to the topics discussed in this episode can be found here: The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update, Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series and WAO Guideline for the Management of Hereditary Angioedema.

Meet the host

Professor Christopher Edwards.jpg

Thomas Buttgereit, MD

Thomas Buttgereit is a dermatologist and allergist at the Angioedema Center of Reference and Excellence (ACARE) Berlin. He regularly gives consultations for patients with different types of recurrent angioedema including patients with HAE. His special interests are clinical and basic research on mast cell-mediated angioedema, HAE due to C1 inhibitor (C1INH) deficiency and HAE with normal C1INH.

Disclosures: Thomas Buttgereit is or recently was a speaker and/or advisor for AstraZeneca, BioCryst, CSL-Behring, GSK, Hexal, KalVista, Medac, Novartis, Pharming, Roche, Sanofi, and Takeda.

These podcasts are brought to you by the ACARE network. The ACARE program, initiated by GA2LEN and HAE International, aims to establish and accredit a network of angioedema centres. The purpose of this collaborative network is to enhance angioedema care and research, in order to improve patient outcomes.

Welcome: